C25-modified rifamycin derivatives with improved activity against Mycobacterium abscessus.
Paulowski L, Beckham KSH, Johansen MD, Berneking L, Van N, Degefu Y, Staack S, Sotomayor FV, Asar L, Rohde H, Aldridge BB, Aepfelbacher M, Parret A, Wilmanns M, Kremer L, Combrink K, Maurer FP.
Paulowski L, et al. Among authors: asar l.
PNAS Nexus. 2022 Aug 9;1(4):pgac130. doi: 10.1093/pnasnexus/pgac130. eCollection 2022 Sep.
PNAS Nexus. 2022.
PMID: 36714853
Free PMC article.